Ibritumomab Tiuxetan and Von willebrand factor recombinant Intravenous
Determining the interaction of Ibritumomab Tiuxetan and Von willebrand factor recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: von willebrand factor
Brand name: Vonvendi, Wilfactin
Synonyms: Von Willebrand factor (recombinant), von Willebrand Factor (Recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Vonvendi
- Ibritumomab Tiuxetan-Vopac
- Ibritumomab Tiuxetan-Vopac MDS
- Ibritumomab Tiuxetan-Vorapaxar
- Ibritumomab Tiuxetan-Vorapaxar Sulfate
- Ibritumomab Tiuxetan-Voraxaze
- Von willebrand factor recombinant Intravenous-Ibrutinib
- Von willebrand factor recombinant Intravenous-Ibrutinib Capsules
- Von willebrand factor recombinant Intravenous-Ibrutinib Tablets
- Von willebrand factor recombinant Intravenous-Ibu
- Von willebrand factor recombinant Intravenous-IBU Tablets
- Von willebrand factor recombinant Intravenous-Ibu-2